Last reviewed · How we verify
Qishenyiqi dripping pills
Qishenyiqi dripping pills is a Traditional Chinese medicine herbal formulation Small molecule drug developed by Qilu Hospital of Shandong University. It is currently FDA-approved for Angina pectoris, Heart failure, Myocardial infarction recovery.
Qishenyiqi dripping pills is a traditional Chinese medicine formulation that enhances cardiac function and improves blood circulation to support heart health.
Qishenyiqi dripping pills is a traditional Chinese medicine formulation that enhances cardiac function and improves blood circulation to support heart health. Used for Angina pectoris, Heart failure, Myocardial infarction recovery.
At a glance
| Generic name | Qishenyiqi dripping pills |
|---|---|
| Sponsor | Qilu Hospital of Shandong University |
| Drug class | Traditional Chinese medicine herbal formulation |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This herbal combination works by invigorating qi (vital energy) and blood flow, reducing blood stasis, and strengthening myocardial contractility. It is used in traditional Chinese medicine to address deficiency patterns and circulatory dysfunction associated with cardiovascular conditions.
Approved indications
- Angina pectoris
- Heart failure
- Myocardial infarction recovery
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
- Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment (PHASE4)
- Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure (PHASE2)
- Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction (PHASE2)
- Qishenyiqi Dripping Pill for Coronary Microvascular Disease (PHASE4)
- Qishenyiqi for Ventricular Remodeling After Myocardial Infarction (PHASE4)
- Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) (PHASE2)
- A Study of Qishenyiqi Dripping Pills in Healthy Participants (PHASE1)
- A Clinical Research of Qi Deficiency and Blood Stasis Syndrome (Different Disease With Syndrome) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Qishenyiqi dripping pills CI brief — competitive landscape report
- Qishenyiqi dripping pills updates RSS · CI watch RSS
- Qilu Hospital of Shandong University portfolio CI
Frequently asked questions about Qishenyiqi dripping pills
What is Qishenyiqi dripping pills?
How does Qishenyiqi dripping pills work?
What is Qishenyiqi dripping pills used for?
Who makes Qishenyiqi dripping pills?
What drug class is Qishenyiqi dripping pills in?
What development phase is Qishenyiqi dripping pills in?
What are the side effects of Qishenyiqi dripping pills?
Related
- Drug class: All Traditional Chinese medicine herbal formulation drugs
- Manufacturer: Qilu Hospital of Shandong University — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Angina pectoris
- Indication: Drugs for Heart failure
- Indication: Drugs for Myocardial infarction recovery
- Compare: Qishenyiqi dripping pills vs similar drugs
- Pricing: Qishenyiqi dripping pills cost, discount & access